Cleveland BioLabs

Cleveland BioLabs

Employees:
20
Market Cap:
$27.97 million
Revenue:
$3.76 million
5 Year Trend:
16.7%
Net Income:
$-3 million
NASDAQ:
CBLI

Cleveland BioLabs, Inc. (Nasdaq: CBLI) is a clinical-stage biotechnology company with a focus on oncology development. It specializes in research and development of products with the potential to treat cancer and protect against death following acute radiation syndrome. Wikipedia

Cleveland BioLabs
Employees:
20
Market Cap:
$27.97 million
Revenue:
$3.76 million
5 Year Trend:
16.7%
Net Income:
$-3 million
NASDAQ:
CBLI

Cleveland BioLabs, Inc. (Nasdaq: CBLI) is a clinical-stage biotechnology company with a focus on oncology development. It specializes in research and development of products with the potential to treat cancer and protect against death following acute radiation syndrome. Wikipedia